Header Logo

Connection

WARREN C FISKUS to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications WARREN C FISKUS has written about Drug Evaluation, Preclinical.
WARREN C FISKUS
Connection Strength
0.074
Drug Evaluation, Preclinical
  1. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood. 2009 Sep 24; 114(13):2733-43.
    View in: PubMed
    Score: 0.074
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.